In The News
Harvey Norman hit with second class action over ‘junk’ warranties
CIMIC loses appeal against insurers over coverage for Iraq bribery cases
Super Retail appeal to have ‘significant impact’ on settlements, court told
Failed CBA class actions want to stay fight over costs
Self Care wins IP action over FreezeFrame knockoffs
Appeal bid in crypto class action against Google, Meta falls flat
Alceon hit with $3M in damages for ‘misleading’ sale of Qld shopping centre
Sydney light rail class action thrown out on appeal
REST’s reliance on law firms’ advice a winning defence in ASIC case
Harvey Norman hit with class action over ‘junk’ warranties
Please login to bookmarkClose

Australian regenerative medicine company Mesoblast faces a shareholder class action over disclosures related to its Remestemcel-L treatment for COVID-19 complications.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au